Skip to main content
. 2015 Sep 8;44(1):117–133. doi: 10.1093/nar/gkv885

Figure 3.

Figure 3.

Elevated EPC1 expression in invasive and chemoresistant tumor cells. (A) Endogenous EPC1 and E2F1 expression levels in different cancer cell lines as assessed by Western blot. Actin was used for loading control. (B) Protein levels of endogenous E2F1 and EPC1 in epirubicin-resistant MCF7 human breast cancer cells (MCF7-EPIR) and parental cells (left). Protein levels of E2F1 and EPC1 in cisplatin (cDDP, 30 μM) treated SK-Mel-147 cells expressing sh.E2F1 or sh.control compared with untreated cells (right). Actin was used for loading control.